Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones.
Neoplasia (New York, N.Y.)
Marchetti, Antonio A; Milella, Michele M; Felicioni, Lara L; Cappuzzo, Federico F; Irtelli, Luciana L; Del Grammastro, Maela M; Sciarrotta, Mariagrazia M; Malatesta, Sara S; Nuzzo, Carmen C; Finocchiaro, Giovanna G; Perrucci, Bruno B; Carlone, Donatella D; Gelibter, Alain J AJ; Ceribelli, Anna A; Mezzetti, Andrea A; Iacobelli, Stefano S; Cognetti, Francesco F; Buttitta, Fiamma F